NCT04648189 2023-10-19Cetuxibab to Reduce Circulating Tumor Cells in Early Stage NSCLCThe Netherlands Cancer InstitutePhase 2 Withdrawn
NCT01640444 2019-04-11VISNU-2Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)Phase 2 Completed240 enrolled